TELEFLEX INCORPORATED (TFX) Spending and interest coverage
- R&D / revenue · 12 months: Value 8.10%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 1.14%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 8.10% | Research and development expense / revenue. Period ending 2026-06-30. $182.51M ÷ $2.25B × 100 ≈ 8.10% |
| Stock-based compensation / revenue · 12 months | 1.14% | Share-based compensation / revenue. Period ending 2026-06-30. $25.59M ÷ $2.25B × 100 ≈ 1.14% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 182.51M USD | Research and Development Expense |
| Revenue | 2.25B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 25.59M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 44.44M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $182.51M | $2.25B | $25.59M | $44.44M | (m) | 8.10% | 1.14% | (m) | (m) |
| 2026-03-31 | $163.87M | $2.13B | $25.81M | $62.76M | (m) | 7.71% | 1.21% | (m) | (m) |
| 2025-12-31 | $144.78M | $1.99B | $25.70M | $118.37M | (m) | 7.27% | 1.29% | (m) | (m) |
| 2025-09-28 | $176.71M | $3.19B | $30.42M | $-238.40M | (m) | 5.54% | 0.95% | (m) | (m) |
| 2025-06-29 | $158.20M | $3.04B | $30.38M | $319.81M | (m) | 5.20% | 1.00% | (m) | (m) |
| 2025-03-30 | $160.78M | $3.01B | $32.05M | $281.38M | (m) | 5.34% | 1.06% | (m) | (m) |
| 2024-12-31 | $161.67M | $3.05B | $31.35M | $151.01M | (m) | 5.31% | 1.03% | (m) | (m) |
| 2024-09-29 | $152.98M | $3.03B | $33.06M | $343.86M | (m) | 5.06% | 1.09% | (m) | (m) |
| 2024-06-30 | $151.83M | $3.01B | $33.18M | $359.86M | $92.83M | 5.05% | 1.10% | 3.88× | Reported |
| 2024-03-31 | $150.18M | $3.00B | $31.58M | $386.55M | $89.43M | 5.00% | 1.05% | 4.32× | Reported |
| 2023-12-31 | $154.35M | $2.97B | $31.46M | $506.31M | $85.08M | 5.19% | 1.06% | 5.95× | Reported |
| 2023-10-01 | $161.25M | $2.96B | $29.55M | $552.43M | $78.34M | 5.45% | 1.00% | 7.05× | Reported |
| 2023-07-02 | $161.44M | $2.90B | $28.44M | $519.57M | $68.53M | 5.57% | 0.98% | 7.58× | Reported |
| 2023-04-02 | $158.93M | $2.86B | $28.94M | $511.16M | $62.18M | 5.56% | 1.01% | 8.22× | Reported |
| 2022-12-31 | $153.82M | $2.79B | $27.22M | $499.73M | $54.26M | 5.51% | 0.98% | 9.21× | Reported |
| 2022-09-25 | $146.86M | $2.79B | $25.68M | $526.20M | $47.22M | 5.25% | 0.92% | 11.14× | Reported |
| 2022-06-26 | $140.91M | $2.81B | $24.05M | $634.73M | $45.84M | 5.02% | 0.86% | 13.85× | Reported |
| 2022-03-27 | $137.25M | $2.82B | $22.89M | $628.20M | $50.59M | 4.87% | 0.81% | 12.42× | Reported |
| 2021-12-31 | $130.84M | $2.81B | $22.94M | $628.10M | $56.97M | 4.66% | 0.82% | 11.03× | Reported |
| 2021-09-26 | $128.81M | $2.76B | $23.05M | $568.11M | $63.68M | 4.67% | 0.84% | 8.92× | Reported |
| 2021-06-27 | $126.22M | $2.69B | $23.95M | $459.23M | $68.34M | 4.70% | 0.89% | 6.72× | Reported |
| 2021-03-28 | $122.30M | $2.54B | $22.56M | $369.42M | $67.85M | 4.81% | 0.89% | 5.44× | Reported |
| 2020-12-31 | $119.75M | $2.54B | $20.74M | $423.07M | $66.49M | 4.72% | 0.82% | 6.36× | Reported |
| 2020-09-27 | $117.11M | $2.51B | $21.66M | $454.92M | $65.05M | 4.67% | 0.86% | 6.99× | Reported |
| 2020-06-28 | $115.87M | $2.53B | $22.72M | $440.45M | $67.94M | 4.59% | 0.90% | 6.48× | Reported |
| 2020-03-29 | $114.10M | $2.61B | $24.68M | $509.10M | $73.02M | 4.37% | 0.94% | 6.97× | Reported |
| 2019-12-31 | $113.86M | $2.60B | $26.94M | $427.25M | $80.27M | 4.39% | 1.04% | 5.32× | Reported |
| 2019-09-29 | $110.53M | $2.56B | $26.01M | $419.59M | $86.25M | 4.32% | 1.02% | 4.86× | Reported |
| 2019-06-30 | $108.91M | $2.52B | $24.40M | $384.07M | $93.88M | 4.33% | 0.97% | 4.09× | Reported |
| 2019-03-31 | $107.33M | $2.47B | $23.43M | $310.10M | $99.77M | 4.34% | 0.95% | 3.11× | Reported |
| 2018-12-31 | $106.21M | $2.45B | $22.44M | $321.70M | $103.02M | 4.34% | 0.92% | 3.12× | Reported |
| 2018-09-30 | $103.88M | $2.40B | $21.36M | $293.34M | $103.42M | 4.32% | 0.89% | 2.84× | Reported |
| 2018-07-01 | $98.71M | $2.33B | $20.61M | $321.59M | $97.52M | 4.24% | 0.89% | 3.30× | Reported |
| 2018-04-01 | $92.97M | $2.25B | $19.95M | $398.30M | $90.76M | 4.14% | 0.89% | 4.39× | Reported |
| 2017-12-31 | $84.77M | $2.15B | $19.41M | $372.28M | $82.55M | 3.95% | 0.90% | 4.51× | Reported |
| 2017-10-01 | $74.99M | $2.07B | $18.85M | $348.40M | $75.25M | 3.63% | 0.91% | 4.63× | Reported |
| 2017-07-02 | $68.86M | $1.99B | $18.46M | $324.54M | $66.87M | 3.47% | 0.93% | 4.85× | Reported |
| 2017-04-02 | $64.05M | $1.93B | $17.67M | $312.77M | $58.88M | 3.32% | 0.92% | 5.31× | Reported |
| 2016-12-31 | $58.58M | $1.87B | $16.87M | $319.45M | $54.94M | 3.14% | 0.90% | 5.81× | Reported |
| 2016-09-25 | $56.11M | $1.84B | $16.63M | $349.17M | $52.22M | 3.05% | 0.90% | 6.69× | Reported |
| 2016-06-26 | $53.62M | $1.83B | $15.29M | $339.24M | $53.63M | 2.94% | 0.84% | 6.32× | Reported |
| 2016-03-27 | $51.59M | $1.81B | $14.07M | $317.78M | $57.94M | 2.86% | 0.78% | 5.49× | Reported |
| 2015-12-31 | $52.12M | $1.81B | $14.47M | $315.89M | $61.32M | 2.88% | 0.80% | 5.15× | Reported |
| 2015-09-27 | $56.13M | $1.80B | $13.48M | $288.30M | $64.49M | 3.12% | 0.75% | 4.47× | Reported |
| 2015-06-28 | $58.44M | $1.81B | $13.63M | $293.68M | $67.37M | 3.22% | 0.75% | 4.36× | Reported |
| 2015-03-29 | $59.86M | $1.83B | $12.98M | $291.45M | $67.23M | 3.27% | 0.71% | 4.34× | Reported |
| 2014-12-31 | $61.04M | $1.84B | $12.23M | $284.86M | $65.46M | 3.32% | 0.66% | 4.35× | Reported |
| 2014-09-28 | $61.68M | $1.81B | $12.57M | $269.77M | $62.99M | 3.40% | 0.69% | 4.28× | Reported |
| 2014-06-29 | $62.45M | $1.77B | $11.83M | $253.88M | $59.75M | 3.53% | 0.67% | 4.25× | Reported |
| 2014-03-30 | $64.10M | $1.72B | $12.15M | $242.88M | $58.12M | 3.72% | 0.71% | 4.18× | Reported |
| 2013-12-31 | $65.05M | $1.70B | $11.87M | $233.26M | $56.91M | 3.83% | 0.70% | 4.10× | Reported |
| 2013-09-30 | (m) | $1.66B | (m) | $237.64M | (m) | (m) | (m) | (m) | (m) |
| 2013-09-29 | $63.43M | $1.66B | $10.88M | $237.64M | $57.19M | 3.81% | 0.65% | 4.16× | Reported |
| 2013-06-30 | $62.55M | $1.62B | $10.39M | $221.44M | $61.73M | 3.86% | 0.64% | 3.59× | Reported |
| 2013-03-31 | $59.73M | $1.58B | $9.70M | $222.41M | $65.55M | 3.77% | 0.61% | 3.39× | Reported |
| 2012-12-31 | $56.28M | $1.55B | $8.62M | $-97.38M | $69.56M | 3.63% | 0.56% | -1.40× | Reported |
| 2012-09-30 | $52.95M | $1.57B | $7.68M | $-89.14M | $74.15M | 3.37% | 0.49% | -1.20× | Reported |
| 2012-07-01 | $50.50M | $1.57B | $7.03M | $-77.08M | $74.84M | 3.22% | 0.45% | -1.03× | Reported |
| 2012-06-30 | (m) | $1.53B | (m) | $-80.68M | (m) | (m) | (m) | (m) | (m) |
| 2012-04-01 | $49.26M | $1.56B | $6.80M | $-86.89M | $72.38M | 3.15% | 0.44% | -1.20× | Reported |
| 2012-03-31 | (m) | $1.53B | (m) | $-89.52M | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $48.73M | $1.53B | $3.99M | $233.17M | $70.32M | 3.19% | 0.26% | 3.32× | Reported |
| 2011-09-25 | $48.27M | $1.63B | $4.34M | $243.17M | $72.48M | 2.96% | 0.27% | 3.35× | Reported |
| 2011-06-26 | $46.52M | $1.60B | $5.45M | $232.74M | $73.35M | 2.90% | 0.34% | 3.17× | Reported |
| 2011-03-27 | $44.35M | $1.82B | $6.87M | $261.61M | $77.19M | 2.43% | 0.38% | 3.39× | Reported |
| 2010-12-31 | $42.62M | $1.80B | $9.62M | $273.59M | $80.03M | 2.37% | 0.53% | 3.42× | Reported |
| 2010-09-26 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-27 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $36.69M | $1.77B | $8.79M | $256.85M | $89.46M | 2.08% | 0.50% | 2.87× | Reported |
| 2009-09-27 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $32.60M | $1.91B | $8.12M | $238.96M | $121.59M | 1.70% | 0.42% | 1.97× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |